مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

301
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

354
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

INTERFERON ALPHA-2B THERAPY IN CHRONIC HEPATITIS DELTA

Pages

  1-5

Abstract

 Background: Approximately 5% of hepatitis B virus (HBV) carriers are coinfected with HEPATITIS D virus (HDV). HBV/HDV coinfection is a major cause of cirrhosis and end stage liver disease in chronic HBsAg carriers. The only approved therapy for chronic HEPATITIS Delta is interferon alpha (IFN a) in either pegylated or conventional forms. Although higher doses and longer durations of IFN a therapy in HBV/HDV coinfected patients are currently applied, yet treatment response is low.Objectives: We aimed to determine the efficacy of IFN a-2b therapy in patients with HBV/HDV coinfection.Patients and Methods: In this cross sectional study, 20 HBsAg carriers with positive Anti-HDVAb and RT-PCR for HDV RNA were recruited and treated for three year duration with 5 million units (MU) of IFN a-2b, three times weekly or one year with 5 MU of IFN a-2b daily. Sustained virological response (SVR) was defined as a negative qualitative HDV RT-PCR, 6 months after treatment cessation.Results: Overall, 3 (15%) subjects achieved SVR, 10 cases (50%) relapsed after treatment cessation and 7 (35%) patients did not clear HDV during the treatment.Conclusions: HDV coinfection with HBV had very low response rate to high doses and long durations of IFN a-2b therapy.

Cites

References

  • No record.

    • Cite

    APA: Copy

    KESHVARI, MARYAM, ALAVIAN, SEYED MOAYED, SHARAFI, HEIDAR, KARIMI, GHARIB, & GHOLAMI FESHARAKI, MOHAMMAD. (2014). INTERFERON ALPHA-2B THERAPY IN CHRONIC HEPATITIS DELTA. HEPATITIS MONTHLY, 14(3), 1-5. SID. https://sid.ir/paper/306572/en

    Vancouver: Copy

    KESHVARI MARYAM, ALAVIAN SEYED MOAYED, SHARAFI HEIDAR, KARIMI GHARIB, GHOLAMI FESHARAKI MOHAMMAD. INTERFERON ALPHA-2B THERAPY IN CHRONIC HEPATITIS DELTA. HEPATITIS MONTHLY[Internet]. 2014;14(3):1-5. Available from: https://sid.ir/paper/306572/en

    IEEE: Copy

    MARYAM KESHVARI, SEYED MOAYED ALAVIAN, HEIDAR SHARAFI, GHARIB KARIMI, and MOHAMMAD GHOLAMI FESHARAKI, “INTERFERON ALPHA-2B THERAPY IN CHRONIC HEPATITIS DELTA,” HEPATITIS MONTHLY, vol. 14, no. 3, pp. 1–5, 2014, [Online]. Available: https://sid.ir/paper/306572/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button